Sign In

Dr. Bartosz Adam Walczyszyn M.D.

Medical Oncology Physician

/

Hematology (Internal Medicine) Physician

/

Medical Oncology Physician

/

Hematology & Oncology Physician

Phone, Open Hours, Reviews & Information

170 Medical Park Road, Mooresville, North Carolina 28117, United States
Spoken Languages: English, Polish
Gender: Male

 

Pharmacy Blue Star Customer Rating Customer Ratings

Reviews about Bartosz Adam Walczyszyn

No reviews. Be first - Add your review about Dr. Bartosz Adam Walczyszyn M.D.

Log in or sign up to post new review

An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.

An internist with additional training who specializes in diseases of the blood, spleen and lymph. This specialist treats conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia and lymphoma.

An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.

An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.

Source: NUCC, CMS

Health Insurance Plans Bartosz Adam Walczyszyn accepts

Issuer Network State Plan Year New Patients Last Updated
Cigna HealthCare of North Carolina, Inc. PREFERRED NC 2025 accepting Nov 12 2024
Celtic Insurance Company PREFERRED NC 2025 accepting Nov 18 2024
CareSource North Carolina Co. PREFERRED NC 2025 accepting Nov 19 2024

Source: CMS.gov, HealthPorta API